Product
Corifollitropin alfa
Aliases
MK-8962, Org 36286, SCH 900962
10 clinical trials
9 indications
Indication
Ovulation InductionIndication
HypogonadismIndication
hypogonadotropic hypogonadismIndication
Ovarian ReserveIndication
Non RespondersIndication
In vitro fertilization (IVF)Indication
In Vitro FertilizationIndication
infertilityIndication
WomanClinical trial
A Phase II, Randomized, Controlled, Open-label, Feasibility Trial to Evaluate if a Single or Repeated Dose of Org 36286 (Corifollitropin Alfa) Followed by a Low Daily Dose of Either hCG or Recombinant FSH Can Induce Monofollicular Growth in Women With WHO Group II Anovulatory InfertilityStatus: Terminated, Estimated PCD: 2008-04-03
Clinical trial
A Phase III, Multi-center, Open Label, Uncontrolled Trial to Investigate the Efficacy and Safety of MK-8962 (Corifollitropin Alfa) in Combination With Human Chorionic Gonadotropin (hCG) in Inducing Increased Testicular Volume and Spermatogenesis in Adult Men With Hypogonadotropic Hypogonadism Who Remain Azoospermic When Treated With hCG Alone (Phase III; Protocol No. MK-8962-031-00 [Also Known as SCH 900962, P07937])Status: Completed, Estimated PCD: 2015-04-08
Clinical trial
A Randomized Comparison of One Controlled Ovarian Stimulation With Corifollitropin Alfa Versus up to Three Modified Natural Cycles in Expected and Established Poor RespondersStatus: Recruiting, Estimated PCD: 2024-09-30
Clinical trial
A Phase III, Multi-Center, Open Label, Single-Group Trial to Investigate the Efficacy and Safety of MK-8962 (Corifollitropin Alfa) in Combination With Human Chorionic Gonadotropin (hCG) for Initiation or Restoration of Puberty as Assessed by Increased Testicular Volume in Adolescent Males 14 to <18 Years Old With Hypogonadotropic Hypogonadism (MK-8962-043)Status: Completed, Estimated PCD: 2020-05-05
Clinical trial
A Phase III, Uncontrolled Trial to Assess the Non-immunogenicity and Safety of Org 36286 in Patients Undergoing Repeated Controlled Ovarian Stimulation Cycles Using a Multiple Dose GnRH Antagonist ProtocolStatus: Completed, Estimated PCD: 2009-02-17
Clinical trial
A Phase III, Randomized, Double-Blind, Active-Controlled, Non-Inferiority Clinical Trial to Investigate the Efficacy and Safety of a Single Injection of Org 36286 (Corifollitropin Alfa) to Induce Multifollicular Development for Controlled Ovarian Stimulation Using Daily Recombinant FSH as ReferenceStatus: Completed, Estimated PCD: 2007-11-19
Clinical trial
Reduction of Progesterone Elevation at Trigger in Poor Responder Bologna' Criteria Patients After Controlled Ovarian Stimulation With Long Acting Standard Stimulation Protocol Compared With Conventional Daily Protocol: a Single Center Prospective Randomized Fase IV TrialStatus: Completed, Estimated PCD: 2024-01-19
Clinical trial
An Observational Single Center Study to Identify the Relationship Between Serum AMH Dynamics and Early or Normal Ovarian Response to Corifollitropin Alfa (ACO Study)Status: Recruiting, Estimated PCD: 2023-06-30
Clinical trial
A Phase III, Randomized, Double-blind, Active-controlled, Equivalence Clinical Trial to Investigate the Efficacy and Safety of a Single Injection of 100 µg Org 36286 (Corifollitropin Alfa) to Induce Multifollicular Development for Controlled Ovarian Stimulation (COS) Using Daily Recombinant FSH (recFSH) as a ReferenceStatus: Completed, Estimated PCD: 2007-07-07
Clinical trial
Follow-up Protocol to Collect the Outcome and Safety of Frozen-thawed Embryo Transfer (FTET) Cycles After Cryopreservation of Embryos in Clinical Study P06029 (Phase 3; Protocol No. P06031)Status: Completed, Estimated PCD: 2013-07-24